-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Amdocs, Lowers Price Target to $92

Benzinga·02/05/2026 15:41:13
Listen to the news
Barclays analyst Tavy Rosner maintains Amdocs (NASDAQ:DOX) with a Overweight and lowers the price target from $111 to $92.